Departmental Papers (Dental)
Medical Molecular Farming: Production of Antibodies, Biopharmaceuticals and Edible Vaccines in Plants
Date of this Version
Trends in Plant Science
The use of plants for medicinal purposes dates back thousands of years but genetic engineering of plants to produce desired biopharmaceuticals is much more recent. As the demand for biopharmaceuticals is expected to increase, it would be wise to ensure that they will be available in significantly larger amounts, on a cost-effective basis. Currently, the cost of biopharmaceuticals limits their availability. Plant-derived biopharmaceuticals are cheap to produce and store, easy to scale up for mass production, and safer than those derived from animals. Here, we discuss recent developments in this field and possible environmental concerns.
<2001>© . This manuscript version is made available under the CC-BY-NC-ND 4.0 license http://creativecommons.org/licenses/by-nc-nd/4.0/
Daniell, H., Streatfield, S. J., & Wycoff, K. (2001). Medical Molecular Farming: Production of Antibodies, Biopharmaceuticals and Edible Vaccines in Plants. Trends in Plant Science, 6 (5), 219-226. Retrieved from https://repository.upenn.edu/dental_papers/283
Date Posted: 01 March 2022
This document has been peer reviewed.
At the time of publication, author Henry Daniell was affiliated with the University of Central Florida. Currently, he is a faculty member at the School of Dental Medicine at the University of Pennsylvania